KELLY CLARKE: Open Payments
NPI 1922544766 · ELIZABETH CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 13 payments from 11 companies in 2025. Trend: 2023 $1,346 · 2024 $880 · 2025 $480
Food & beverage: $380Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $144 |
| SANOFI US SERVICES INC. | 1 | $104 |
| SpringWorks Therapeutics, Inc. | 1 | $61 |
| PFIZER INC. | 1 | $27 |
| Eisai Inc. | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $23 |
| TerSera Therapeutics LLC | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $19 |
Products named: TIVDAK, Lenvima, Orserdu, JAKAFI, Zoladex, PEMAZYRE, Tecentriq, RYBREVANT.
Industry payments across NC — which companies pay providers there.
